23andMe
me targeting a genetically validated approach to anti cancer therapy | 23andMe
Company
Deck Type
Sector
Industry
Deck date
April 2023
Slide
46 of 57
Similar slides by 23andMe
See diffirences between slides (animation)
Investor Presentation
August 2022
me targeting a genetically validated approach to anti cancer therapy | 23andMe
Related slides by other companies
Adagio Therapeutics
Investor Conference
January 2023
a combination approach of two antibodies targeting distinct | Adagio Therapeutics
BioNTech
Results
May 2021
neo stim personalized targeted adoptive cell therapy addresses limitations of til cell therapy approaches | BioNTech
Immatics
Investor Presentation
November 2023
why cells | Immatics
Other recent decks by 23andMe
See all presentations (7 decks)
Investor Presentation
January 2024
Investor Presentation
August 2022
Investor Presentation
February 2022
Investor Day
January 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io